Early Virologic Failure and Rescue Therapy of Tenofovir, Abacavir, and Lamivudine for Initial Treatment of HIV-1 Infection: TONUS Study-Reference-Cited by-同舟云学术

Early Virologic Failure and Rescue Therapy of Tenofovir, Abacavir, and Lamivudine for Initial Treatment of HIV-1 Infection: TONUS Study

Published:2005-12 Issue:6 Volume:6 Page:291-301
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Landman R.,Descamps D.,Peytavin G.,Trylesinski A.,Katlama C.,Girard P.M.,Bonnet B.,Yeni P.,Bentata M.,Michelet C.,Benalycherif A.,Brun Vezinet F.,Miller M.D.,Flandre P.,

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

http://www.tandfonline.com/doi/pdf/10.1310/9DQP-R7JA-75ED-RBCP

Reference18 articles.

1. A systematic review of the associations between dose regimens and medication compliance

2. Perspectives on Adherence and Simplicity for HIV-Infected Patients on Antiretroviral Therapy

3. Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal

4. Once‐Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus–Infected Patients

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of a single-class maintenance strategy with nucleoside reverse transcriptase inhibitors in HIV/AIDS;Antiviral Therapy;2014

2. Use of Nucleoside Reverse Transcriptase Inhibitor–only Regimens in HIV-infected Children and Adolescents;Pediatric Infectious Disease Journal;2013-09

3. Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial;Antiviral Therapy;2013

4. A Review of the Virological Efficacy of the 4 World Health Organization–Recommended Tenofovir-Containing Regimens for Initial HIV Therapy;Clinical Infectious Diseases;2012-03-15

5. Combination Nucleoside/Nucleotide Reverse Transcriptase Inhibitors for Treatment of HIV Infection;Expert Opinion on Pharmacotherapy;2011-12-09